Nat. Biotechnol. 24, 268 (2006), corrected 27 March 2006
In the print version of this article and the version originally published online, Carole Ben-Maimon was incorrectly listed as president and CEO of Barr Pharmaceuticals. She is, in fact, president and COO of Duramed Research, a subsidiary of Barr Pharmaceuticals. Her email address was also incorrect; her correct email address is cbenmaimon@barrlabs.com. The error has been corrected in the PDF version of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt0306-268a
Rights and permissions
About this article
Cite this article
Ben-Maimon, C., Garnick, R. Erratum: Biogenerics at the crossroads. Nat Biotechnol 24, 467 (2006). https://doi.org/10.1038/nbt0406-467d
Issue Date:
DOI: https://doi.org/10.1038/nbt0406-467d
